1 |
Kulkarni SK, Dhir A, Akula KK (2009) Potentials of curcumin as an antidepressant. Scientific World Journal 9:1233-1241
DOI
|
2 |
Witkin JM, Leucke S, Thompson LK, Lynch RA, Ding C, Heinz B, Catlow JT, Gleason SD, Li X (2013) Further evaluation of the neuropharmacological determinants of the antidepressant-like effects of curcumin. CNS Neurol Disord Drug Targets 12:498-505
DOI
|
3 |
Ji HF, Shen L (2014) The multiple pharmaceutical potential of curcumin in Parkinson's disease. CNS Neurol Disord Drug Targets 13:369-373
DOI
|
4 |
Kwon Y (2014) Curcumin as a cancer chemotherapy sensitizing agent. J Korean Soc Appl Biol Chem 57:273-280
DOI
|
5 |
Parasuraman S, Zhen KM, Banik U, Christapher PV (2017) Ameliorative effect of curcumin on olanzapine-induced obesity in Sprague-Dawley rats. Pharmacognosy Res 9:247-252
DOI
|
6 |
Khatri DK, Juvekar AR (2016) Kinetics of inhibition of monoamine oxidase using curcumin and ellagic Acid. Pharmacogn Mag 12:S116-S120
DOI
|
7 |
Hwang KW, Son D, Jo HW, Kim CH, Seong KC, Moon JK (2016) Levels of curcuminoid and essential oil compositions in turmerics (Curcuma longa L.) grown in Korea. Appl Biol Chem 59:209-215
DOI
|
8 |
Ramsay RR, Tipton KF (2017) Assessment of enzyme inhibition: a review with examples from the development of monoamine oxidase and cholinesterase inhibitory drugs. Molecules 22:E1192
DOI
|
9 |
Youdim MB, Edmondson D, Tipton KF (2006) The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7:295-309
DOI
|
10 |
Fisar Z (2016) Drugs related to monoamine oxidase activity. Prog Neuropsychopharmacol Biol Psychiatry 69:112-124
DOI
|
11 |
Pathak A, Srivastava AK, Singour PK, Gouda P (2016) Synthetic and natural monoamine oxidase inhibitors as potential lead compounds for effective therapeutics. Cent Nerv Syst Agents Med Chem 16:81-97
DOI
|
12 |
Badavath VN, Baysal Y, Ucar G, Sinha BN, Jayaprakash V (2015) Monoamine oxidase inhibitory activity of novel pyrazoline analogues: curcumin based design and synthesis. ACS Med Chem Lett 7:56-61
|
13 |
Baek SC, Lee HW, Ryu HW, Kang MG, Park D, Kim SH, Cho ML, Oh SR, Kim H (2018) Selective inhibition of monoamine oxidase A by hispidol. Bioorg Med Chem Lett 28: 584-588
DOI
|
14 |
Lee HW, Ryu HW, Kang MG, Park D, Oh SR, Kim H (2016) Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens. Bioorg Med Chem Lett 26:4714-4719
DOI
|
15 |
Anderson AM, Mitchell MS, Mohan RS (2000) Isolation of curcumin from turmeric. J Chem Educ 77:359-360
DOI
|
16 |
Dairam A, Limson JL, Watkins GM, Antunes E, Daya S (2007) Curcuminoids, curcumin, and demethoxycurcumin reduce lead-induced memory deficits in male Wistar rats. J Agric Food Chem 55:1039-1044
DOI
|
17 |
Lee HW, Ryu HW, Baek SC, Kang MG, Park D, Han HY, An JH, Oh SR, Kim H (2017) Potent inhibitions of monoamine oxidase A and B by acacetin and its 7-O-(6-O-malonylglucoside) derivative from Agastache rugosa. Int J Biol Macromol 104:547-553
DOI
|
18 |
Lee HW, Ryu HW, Kang MG, Park D, Lee H, Shin HM, Oh SR, Kim H (2017) Potent inhibition of monoamine oxidase A by decursin from Angelica gigas Nakai and by wogonin from Scutellaria baicalensis Georgi. Int J Biol Macromol 97:598-605
DOI
|
19 |
Lee HW, Ryu HW, Kang MG, Park D, Oh SR, Kim H (2017) Selective inhibition of monoamine oxidase A by purpurin, an anthraquinone. Bioorg Med Chem Lett 27:1136-1140
DOI
|
20 |
Lee HW, Choi H, Nam SJ, Fenical W, Kim H (2017) Potent inhibition of monoamine oxidase B by a piloquinone from a marine-derived Streptomyces sp. CNQ-027. J Microbiol Biotechnol 27:785-790
DOI
|
21 |
Dhiman P, Malik N, Khatkar A (2017) 3D-QSAR and in-silico studies of natural products and related derivatives as monoamine oxidase inhibitors. Curr Neuropharmacol doi: 10.2174/1570159X15666171128 143650. [Epub ahead of print]
|